I received a Bsc (Hons) in Cognitive neuroscience and psychology from the University of Manchester in 2015 and was awarded with a PhD in neuropsychopharmacology from the same university in 2019. I was the recipient of the highly competitive President’s Doctoral Scholars Award, which partly funded my PhD studies. Throughout my PhD, I investigated the effects of chronic treatment with antipsychotics on cognition and its neural correlates in an animal model for cognitive impairment associated with schizophrenia using a combination of behavioural and in-vivo electrophysiological techniques.
I am now a research associate working with Dr Samuel Barnes in the Dementia Research Institute (UK DRI) at Imperial College. We use a combination of in-vivo calcium imaging, electrophysiological and behavioural techniques to investigate the dynamics of homeostatic neural plasticity in aging and neurodegeneration.
et al., 2019, Global brain volume reductions in a sub-chronic phencyclidine animal model for schizophrenia and their relationship to recognition memory, Journal of Psychopharmacology, Vol:33, ISSN:0269-8811, Pages:1274-1287
et al., 2018, NMDA receptor antagonist rodent models for cognition in schizophrenia and identification of novel drug treatments, an update, Neuropharmacology, Vol:142, ISSN:0028-3908, Pages:41-62
Sahin C, Doostdar N, Neill JC, 2016, Towards the development of improved tests for negative symptoms of schizophrenia in a validated animal model, Behavioural Brain Research, Vol:312, ISSN:0166-4328, Pages:93-101